These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32754110)

  • 1. Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
    Polymeropoulos CM; Mohrman MA; Keefe MS; Brzezynski JL; Wang J; Prokosch LS; Polymeropoulos VM; Xiao C; Birznieks G; Polymeropoulos MH
    Front Neurol; 2020; 11():611. PubMed ID: 32754110
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial.
    Polymeropoulos CM; Polymeropoulos VM; Czeisler EL; Fisher MA; Smieszek SP; Xiao C; Birznieks G; Polymeropoulos MH
    Front Neurol; 2022; 13():901467. PubMed ID: 36188367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials.
    Lockley SW; Dressman MA; Licamele L; Xiao C; Fisher DM; Flynn-Evans EE; Hull JT; Torres R; Lavedan C; Polymeropoulos MH
    Lancet; 2015 Oct; 386(10005):1754-64. PubMed ID: 26466871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
    Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tasimelteon for the treatment of non-24-hour sleep-wake disorder.
    Neubauer DN
    Drugs Today (Barc); 2015 Jan; 51(1):29-35. PubMed ID: 25685859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder.
    Johnsa JD; Neville MW
    Ann Pharmacother; 2014 Dec; 48(12):1636-41. PubMed ID: 25204464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A benzodiazepine hypnotic facilitates adaptation of circadian rhythms and sleep-wake homeostasis to an eight hour delay shift simulating westward jet lag.
    Buxton OM; Copinschi G; Van Onderbergen A; Karrison TG; Van Cauter E
    Sleep; 2000 Nov; 23(7):915-27. PubMed ID: 11083601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals.
    Keating GM
    CNS Drugs; 2016 May; 30(5):461-8. PubMed ID: 27003694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tasimelteon for treating non-24-h sleep-wake rhythm disorder.
    Nishimon S; Nishimon M; Nishino S
    Expert Opin Pharmacother; 2019 Jun; 20(9):1065-1073. PubMed ID: 30990759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.
    Emens JS; Eastman CI
    Drugs; 2017 Apr; 77(6):637-650. PubMed ID: 28229310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon.
    Torres R; Fisher M; Birznieks G; Polymeropoulos C; Kay GG; Xiao C; Polymeropoulos MH
    J Sleep Res; 2022 Feb; 31(1):e13430. PubMed ID: 34152055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jet lag: clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trial.
    Spitzer RL; Terman M; Williams JB; Terman JS; Malt UF; Singer F; Lewy AJ
    Am J Psychiatry; 1999 Sep; 156(9):1392-6. PubMed ID: 10484950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of shift work disorder and jet lag.
    Zee PC; Goldstein CA
    Curr Treat Options Neurol; 2010 Sep; 12(5):396-411. PubMed ID: 20842597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal and pharmacological manipulation of the circadian clock: recent developments and future strategies.
    Richardson G; Tate B
    Sleep; 2000 May; 23 Suppl 3():S77-85. PubMed ID: 10809190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel.
    Zee PC; Wang-Weigand S; Wright KP; Peng X; Roth T
    Sleep Med; 2010 Jun; 11(6):525-33. PubMed ID: 20483660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Air travel: effects of sleep deprivation and jet lag.
    Weingarten JA; Collop NA
    Chest; 2013 Oct; 144(4):1394-1401. PubMed ID: 24081353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tasimelteon (Hetlioz™): A New Melatonin Receptor Agonist for the Treatment of Non-24-Hour Sleep-Wake Disorder.
    Bonacci JM; Venci JV; Gandhi MA
    J Pharm Pract; 2015 Oct; 28(5):473-8. PubMed ID: 25092604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preflight adjustment to eastward travel: 3 days of advancing sleep with and without morning bright light.
    Burgess HJ; Crowley SJ; Gazda CJ; Fogg LF; Eastman CI
    J Biol Rhythms; 2003 Aug; 18(4):318-28. PubMed ID: 12932084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.